The ubiquitin-proteasome system meets angiogenesis.

Area of Science:

• Molecular Biology
• Cell Biology
• Biochemistry

Background:

• Endothelial cell function is tightly regulated by a balance of proangiogenic and antiangiogenic factors.
• Pathologic angiogenesis involves a shift favoring endothelial cell growth, often driven by hypoxia-induced VEGF.
• The ubiquitin-proteasome system (UPS) is crucial for regulating protein stability and function.

Purpose of the Study:

• To review recent advances linking the UPS to angiogenesis regulation.
• To highlight the role of ubiquitin modification in controlling angiogenic pathways.
• To explore the therapeutic potential of the UPS in angiogenesis-associated diseases.

Main Methods:

• Literature review of recent research on UPS and angiogenesis.
• Analysis of mechanisms involving ubiquitin modification of angiogenic proteins.
• Discussion of proteolytic and nonproteolytic functions of the UPS in angiogenesis.

Main Results:

• The UPS fine-tunes core proangiogenic proteins, including VEGF and VEGFR-2.
• Ubiquitin modification by the UPS controls both VEGF-dependent and non-VEGF angiogenic pathways.
• Emerging evidence points to both degradation and non-degradative roles of the UPS in angiogenesis.

Conclusions:

• The UPS is a central regulator of angiogenesis, impacting endothelial cell function.
• Targeting the UPS may offer novel therapeutic strategies for angiogenesis-related disorders.
• Understanding UPS mechanisms provides insights into controlling pathologic angiogenesis.